Rosemonde Mandeville
Vorsitzender bei Biophage, Inc.
Profil
Rosemonde Mandeville is currently the Chairman at Biophage, Inc., the Director at Armand-Frappier Foundation, and the Director at Cancer Research Society.
Previously, Dr. Mandeville held positions such as Chairman, President & Chief Executive Officer at Biophage Pharma, Inc. in 2009, and Director at Montec Holdings, Inc. and Phagelux (Canada), Inc. Dr. Mandeville obtained a doctorate degree from the University of Manitoba and an undergraduate degree from Alexandria University.
Aktive Positionen von Rosemonde Mandeville
| Unternehmen | Position | Beginn |
|---|---|---|
| Armand-Frappier Foundation | Direktor/Vorstandsmitglied | 12.10.2011 |
Cancer Research Society
 Cancer Research Society Miscellaneous Commercial ServicesCommercial Services The Cancer Research Society is a non-profit organization that focuses on cancer research. The organization is based in Montreal, Canada. The organization has received support from Stéphane Rousseau, who is a spokesperson for the organization and actively supports their efforts. Max Fehlmann has been the CEO of the Canadian company since 2017. | Direktor/Vorstandsmitglied | 12.10.2011 |
Biophage, Inc.
 Biophage, Inc. Pharmaceuticals: MajorHealth Technology Biophage, Inc. develops pharmaceutical products. The company is headquartered in Montreal, Canada. | Vorsitzender | - |
Ehemalige bekannte Positionen von Rosemonde Mandeville
| Unternehmen | Position | Ende |
|---|---|---|
| Montec Holdings, Inc. | Direktor/Vorstandsmitglied | 05.02.2009 |
Phagelux (Canada), Inc.
 Phagelux (Canada), Inc. BiotechnologyHealth Technology Phagelux (Canada), Inc. specializes in biological products except diagnostic substances. The firm offers its products for solving bacterial problems in agricultural, food safety, animal health, and topical and inhaled treatments to treat various diseases. The company was incorporated on March 11, 2015 and is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | - |
Biophage Pharma, Inc.
 Biophage Pharma, Inc. Pharmaceuticals: MajorHealth Technology Biophage Pharma, Inc. is a biotechnology company. It develops phage-based products and technologies for the detection, prevention and control of bacterial infections. It operates through two divisions: Therapeutic and Biosensors. The Therapeutic division is engaged in the management of bacterial contaminations in the medical, veterinary and environmental. The Biosensors division is to the development and commercialization of novel biosensors. Biophage Pharma was founded in 1995 and is headquartered in Montreal, Canada. | Vorstandsvorsitzender | - |
Ausbildung von Rosemonde Mandeville
| University of Manitoba | Doctorate Degree |
| Alexandria University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Biophage Pharma, Inc.
Biophage Pharma, Inc. Pharmaceuticals: MajorHealth Technology Biophage Pharma, Inc. is a biotechnology company. It develops phage-based products and technologies for the detection, prevention and control of bacterial infections. It operates through two divisions: Therapeutic and Biosensors. The Therapeutic division is engaged in the management of bacterial contaminations in the medical, veterinary and environmental. The Biosensors division is to the development and commercialization of novel biosensors. Biophage Pharma was founded in 1995 and is headquartered in Montreal, Canada. | Health Technology |
| Montec Holdings, Inc. | Technology Services |
| Armand-Frappier Foundation | |
Cancer Research Society
Cancer Research Society Miscellaneous Commercial ServicesCommercial Services The Cancer Research Society is a non-profit organization that focuses on cancer research. The organization is based in Montreal, Canada. The organization has received support from Stéphane Rousseau, who is a spokesperson for the organization and actively supports their efforts. Max Fehlmann has been the CEO of the Canadian company since 2017. | Commercial Services |
Biophage, Inc.
Biophage, Inc. Pharmaceuticals: MajorHealth Technology Biophage, Inc. develops pharmaceutical products. The company is headquartered in Montreal, Canada. | Health Technology |
Phagelux (Canada), Inc.
Phagelux (Canada), Inc. BiotechnologyHealth Technology Phagelux (Canada), Inc. specializes in biological products except diagnostic substances. The firm offers its products for solving bacterial problems in agricultural, food safety, animal health, and topical and inhaled treatments to treat various diseases. The company was incorporated on March 11, 2015 and is headquartered in Toronto, Canada. | Health Technology |
